TickerFactsScreenerDevelopers

Spero Therapeutics, Inc. (SPRO) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $335.0K2017: $1.98M2018: $3.97M2019: $18.15M2020: $9.33M2021: $18.26M2022: $53.51M2023: $103.78M2024: $47.98M2025: $66.80M$66.80M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$66.80M+39.2%
2024$47.98M-53.8%
2023$103.78M+94.0%
2022$53.51M+193.1%
2021$18.26M+95.7%
2020$9.33M-48.6%
2019$18.15M+357.6%
2018$3.97M+100.4%
2017$1.98M+490.7%
2016$335.0K—